4.2 Review

Diabetic cardiomyopathy: where we are and where we are going

期刊

KOREAN JOURNAL OF INTERNAL MEDICINE
卷 32, 期 3, 页码 404-421

出版社

KOREAN ASSOC INTERNAL MEDICINE
DOI: 10.3904/kjim.2016.208

关键词

Diabetic cardiomyopathies; Heart failure; Diabetes mellitus

资金

  1. Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Government [2016R1A4A1009895, 2012R1A1A2008177]
  2. National Research Foundation of Korea [2012R1A1A2008177] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

The global burden of diabetes mellitus and its related complications are currently increasing. Diabetes mellitus affects the heart through various mechanisms including microvascular impairment, metabolic disturbance, subcellular component abnormalities, cardiac autonomic dysfunction, and a maladaptive immune response. Eventually, diabetes mellitus can cause functional and structural changes in the myocardium without coronary artery disease, a disorder known as diabetic cardiomyopathy (DCM). There are many diagnostic tools and management options for DCM, although it is difficult to detect its development and effectively prevent its progression. In this review, we summarize the current research regarding the pathophysiology and pathogenesis of DCM. Moreover, we discuss emerging diagnostic evaluation methods and treatment strategies for DCM, which may help our understanding of its underlying mechanisms and facilitate the identification of possible new therapeutic targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据